By Matt Whittaker / NewsBreak Denver
(Denver, Colo.) State officials warned the public about potential health issues with medical marijuana sold in Denver and Northglenn dispensaries. The company that produced the tainted weed has issued a voluntary recall.
The Marijuana Enforcement Division of the Colorado Department of Revenue issued a health and safety advisory Friday after identifying potentially unsafe levels of yeast, mold and aspergillus on marijuana flower produced by Physician Preferred Products, which does business as Doc’s Apothecary.
Officials deem it a “threat to public health and safety when marijuana is found to have levels of total yeast and mold and aspergillus above the acceptable limits,” the state said.
Aspergillus is a genus of mold species that can cause infections, fatal diseases and allergic responses, according to the National Library of Medicine. New aspergillus regulations went into effect in Colorado in July.
A state investigation identified harvest batches produced by the company that contained levels of contaminants above acceptable limits sold between March 4, 2022, and Sept. 22, 2022, at the Doc’s Apothecary location at 2100 East 112th Avenue in Northglenn and at 4080 North Globeville Road in Denver.
The investigation also identified hundreds of harvest batches created between Jan. 1, 2020, and Sept. 21, 2022, that were improperly submitted for testing, and it included them in the advisory as a precautionary measure.
“In collaboration with the Marijuana Enforcement Division, Physician Preferred Products LLC initiated a voluntary recall for affected Harvest Batches,” the state said.
Daniel Seaman, general manager of Doc’s Apothecary, said there was a “misinterpretation” between the company and the enforcement division about the company’s curing process.
He said that the company and state worked on the issue since November and reached a mutual agreement for the voluntary recall.
Comments / 11